The aim of this study is to investigate whether enhanced external counterpulsation (EECP) therapy for 7 consecutive weeks will improve cerebral blood flow and possibly over time enhance or slow down breakdown of cognitive function in patients diagnosed with mild cognitive impairment (MCI).
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
8
A noninvasive neuroimaging technique. Administration of 35 hours EECP therapy over a 7 week period. EECP to be administered for 1 hour, 5 times a week.
University of Kansas Medical Center
Kansas City, Kansas, United States
Change in Cognitive Function
Change in cognitive function measured using the Alzheimer's Disease Assessment Scale-cognitive sub-scale (ADAS-cog). Scale is used to determine patient's mental status. The scale has 11 parts and scores range from 0 (no impairment) to 70 (severe impairment).
Time frame: Baseline, Week 7, 6 Month
Change in Ophthalmic blood flow (OBF)
Time frame: Baseline to Week 7
Change in Blood Viscosity
Time frame: Baseline to Week 7
Cholesterol composition of the blood
Time frame: Baseline to week 7
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.